HUT75332A - Compositions containing micronized nebivolol - Google Patents
Compositions containing micronized nebivololInfo
- Publication number
- HUT75332A HUT75332A HU9602272A HU9602272A HUT75332A HU T75332 A HUT75332 A HU T75332A HU 9602272 A HU9602272 A HU 9602272A HU 9602272 A HU9602272 A HU 9602272A HU T75332 A HUT75332 A HU T75332A
- Authority
- HU
- Hungary
- Prior art keywords
- pct
- compositions containing
- containing micronized
- micronized nebivolol
- sec
- Prior art date
Links
- KOHIRBRYDXPAMZ-YHBROIRLSA-N (S,R,R,R)-nebivolol Chemical compound C1CC2=CC(F)=CC=C2O[C@H]1[C@H](O)CNC[C@@H](O)[C@H]1OC2=CC=C(F)C=C2CC1 KOHIRBRYDXPAMZ-YHBROIRLSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 229960000619 nebivolol Drugs 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Dental Preparations (AREA)
Abstract
PCT No. PCT/EP95/00489 Sec. 371 Date Jul. 9, 1996 Sec. 102(e) Date Jul. 9, 1996 PCT Filed Feb. 10, 1995 PCT Pub. No. WO95/22325 PCT Pub. Date Aug. 24, 1995The present invention relates to pharmaceutical compositions containing as active ingredient micronized nebivolol of formula (I) and ways of preparing said compositions. <IMAGE> (1) <IMAGE>
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19798894A | 1994-02-17 | 1994-02-17 | |
PCT/EP1995/000489 WO1995022325A1 (en) | 1994-02-17 | 1995-02-10 | Compositions containing micronized nebivolol |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9602272D0 HU9602272D0 (en) | 1996-10-28 |
HUT75332A true HUT75332A (en) | 1997-05-28 |
HU221848B1 HU221848B1 (en) | 2003-02-28 |
Family
ID=22731545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9602272A HU221848B1 (en) | 1994-02-17 | 1995-02-10 | Pharmaceuticals containing micronized nebivolol |
Country Status (30)
Country | Link |
---|---|
US (1) | US5759580A (en) |
EP (1) | EP0744946B1 (en) |
JP (1) | JP3810079B2 (en) |
KR (1) | KR100361636B1 (en) |
CN (1) | CN1112921C (en) |
AT (1) | ATE212547T1 (en) |
AU (1) | AU688860B2 (en) |
BR (1) | BR9506828A (en) |
CA (1) | CA2182582C (en) |
CY (1) | CY2329B1 (en) |
CZ (1) | CZ290844B6 (en) |
DE (1) | DE69525241T2 (en) |
DK (1) | DK0744946T3 (en) |
ES (1) | ES2171533T3 (en) |
FI (1) | FI117888B (en) |
HU (1) | HU221848B1 (en) |
IL (1) | IL112659A (en) |
MX (1) | MX9603314A (en) |
MY (1) | MY115339A (en) |
NO (1) | NO314712B1 (en) |
NZ (1) | NZ279822A (en) |
PL (1) | PL178505B1 (en) |
PT (1) | PT744946E (en) |
RU (1) | RU2137473C1 (en) |
SG (1) | SG47487A1 (en) |
SI (1) | SI0744946T1 (en) |
SK (1) | SK283250B6 (en) |
TW (1) | TW355683B (en) |
WO (1) | WO1995022325A1 (en) |
ZA (1) | ZA951294B (en) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU226208B1 (en) * | 1994-12-28 | 2008-06-30 | Janssen Pharmaceutica Nv | Use of nebivolol for producing anti-atherogenic pharmaceuticals |
DE69615704T2 (en) | 1995-12-27 | 2002-07-11 | Janssen Pharmaceutica N.V., Beerse | BIOADHESIVE SOLID MEDICINE FORM |
DE19637082A1 (en) | 1996-09-12 | 1998-03-19 | Boehringer Mannheim Gmbh | Rapidly disintegrating pellets |
US7025991B2 (en) * | 1997-06-13 | 2006-04-11 | Nanodel Technologies Gmbh | Drug targeting system, method of its preparation and its use |
AR016827A1 (en) | 1997-08-22 | 2001-08-01 | Smithkline Beecham Corp | PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL TABLET |
AR017512A1 (en) | 1997-08-22 | 2001-09-12 | Smithkline Beecham Corp | TABLETS OF QUICKLY DISPOSABLE METILCELLULOSE FOR ORAL ROUTE ADMINISTRATION AND PROCEDURE TO PREPARE THEM |
US20030152636A1 (en) * | 2000-02-23 | 2003-08-14 | Nanopharm Ag | Method of treating cancer |
US6531158B1 (en) * | 2000-08-09 | 2003-03-11 | Impax Laboratories, Inc. | Drug delivery system for enhanced bioavailability of hydrophobic active ingredients |
ATE437637T1 (en) * | 2001-05-02 | 2009-08-15 | Nitromed Inc | NITROZED AND NITROSYLATED NEBIVOLOL AND ITS METABOLITES, COMPOSITIONS AND METHODS OF USE |
US7803838B2 (en) * | 2004-06-04 | 2010-09-28 | Forest Laboratories Holdings Limited | Compositions comprising nebivolol |
RU2378272C2 (en) | 2004-07-30 | 2010-01-10 | Торрент Фармасьютикалз Лимитед | Nebivolol and pharmaceutically acceptable salts thereof, method of producing said salts and nebivolol pharmaceutical compositions |
US20070021623A1 (en) * | 2004-08-11 | 2007-01-25 | Hetero Drugs Limited | Novel process for preparation of nebivolol intermediates |
US7344907B2 (en) * | 2004-11-19 | 2008-03-18 | International Business Machines Corporation | Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale |
EP1848424B1 (en) * | 2005-01-31 | 2017-04-05 | Mylan Laboratories, Inc | Pharmaceutical composition comprising hydroxylated nebivolol |
WO2006084684A1 (en) * | 2005-02-11 | 2006-08-17 | Stada Arzneimittel Ag | Pharmaceutical compositions comprising nebivolol and a hydrophilic polymer |
EP1803716B1 (en) * | 2005-12-28 | 2012-07-25 | Acino Pharma AG | A process for preparation of racemic nebivolol |
US7560575B2 (en) | 2005-12-28 | 2009-07-14 | Acino Pharma Ag | Process for preparation of racemic Nebivolol |
WO2007083318A1 (en) * | 2006-01-18 | 2007-07-26 | Hetero Drugs Limited | Process for isolation of desired isomers of nebivolol intermediates |
EP1839658A1 (en) * | 2006-03-30 | 2007-10-03 | Hexal A/S | Pharmaceutical composition comprising micronized nebivolol |
DE102006036579A1 (en) * | 2006-08-04 | 2008-02-07 | Alfred E. Tiefenbacher Gmbh & Co.Kg | Composition, useful to treat hypertension, comprises nebivolol as active agent and a polymer carrier material, where the active agent is present in micronized form in a polymer carrier matrix and is essentially free of wetting agent |
ATE462415T1 (en) * | 2006-08-04 | 2010-04-15 | Alfred E Tiefenbacher Gmbh & C | PHARMACEUTICAL COMPOSITION CONTAINING NEBIVOLOL |
UA97813C2 (en) * | 2006-12-05 | 2012-03-26 | Янссен Фармацевтика Н.В. | Fumarate salt of (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
WO2008089549A1 (en) * | 2007-01-22 | 2008-07-31 | Genpharm Ulc | Pharmaceutical compositions comprising nebivolol or a nebivolol analogue |
US20100172972A1 (en) * | 2007-05-21 | 2010-07-08 | Sun Pharmaceutical Industries Limited | Enteric coated pharmaceutical compositions |
US20090030071A1 (en) * | 2007-07-26 | 2009-01-29 | Shaw Andrew A | Treatment of Cardiovascular Disease in Mexican Americans Using Nebivolol |
CN101463024B (en) | 2007-12-21 | 2011-06-08 | 上海现代制药股份有限公司 | Method for preparing RRRS and SSSR type nebivolol intermediate mixture |
US20090181975A1 (en) * | 2008-01-15 | 2009-07-16 | Forest Laboratories Holdings Limited | Nebivolol in the treatment of sexual dysfunction |
ATE533752T1 (en) | 2008-09-08 | 2011-12-15 | Cadila Pharmaceuticals Ltd | IMPROVED MANUFACTURING PROCESS FOR NEBIVOLOL HYDROCHOLORIDE |
IT1395354B1 (en) | 2009-07-23 | 2012-09-14 | Zach System Spa | NEBIVOLOL PREPARATION PROCESS |
IT1397962B1 (en) | 2010-02-11 | 2013-02-04 | Menarini Int Operations Lu Sa | PROCESS FOR NEBIVOLOL PREPARATION. |
KR20110130872A (en) * | 2010-05-28 | 2011-12-06 | 현대약품 주식회사 | Pharmaceutical composition comprising crystalline nebivolol hydrochloride and method for manufacturing the same |
WO2012003181A2 (en) * | 2010-07-02 | 2012-01-05 | Fmc Corporation | Solid forms |
CN105085499B (en) * | 2015-08-07 | 2018-09-25 | 上海现代制药海门有限公司 | The Crystallization Separation method of nebivolol hydrochloric acid intermediate mixture |
CN117503775A (en) | 2017-04-28 | 2024-02-06 | 自由生物有限公司 | Formulations, methods, kits and dosage forms for treating atopic dermatitis and improving stability of active pharmaceutical ingredient |
US20220016025A1 (en) * | 2020-07-08 | 2022-01-20 | Vinayak Dinesh DENDUKURI | Formulations of nebivolol |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60107106A (en) * | 1983-11-15 | 1985-06-12 | Mitsubishi Electric Corp | Curve interpolation system |
CA1337429C (en) * | 1983-12-05 | 1995-10-24 | Guy Rosalia Eugene Van Lommen | Derivatives of 2,2'-iminobisethanol |
CA1337432C (en) * | 1988-03-23 | 1995-10-24 | Raymond M. Xhonneux | Method of lowering the blood pressure |
JPH02264744A (en) * | 1989-04-04 | 1990-10-29 | Kyowa Hakko Kogyo Co Ltd | Optically active p-fluorophenoxy derivative and production thereof |
-
1995
- 1995-01-17 TW TW084100357A patent/TW355683B/en not_active IP Right Cessation
- 1995-02-10 HU HU9602272A patent/HU221848B1/en active IP Right Grant
- 1995-02-10 SI SI9530582T patent/SI0744946T1/en unknown
- 1995-02-10 AU AU17068/95A patent/AU688860B2/en not_active Expired
- 1995-02-10 SG SG1996002228A patent/SG47487A1/en unknown
- 1995-02-10 EP EP95908927A patent/EP0744946B1/en not_active Expired - Lifetime
- 1995-02-10 KR KR1019960704263A patent/KR100361636B1/en not_active IP Right Cessation
- 1995-02-10 US US08/669,415 patent/US5759580A/en not_active Expired - Lifetime
- 1995-02-10 WO PCT/EP1995/000489 patent/WO1995022325A1/en active IP Right Grant
- 1995-02-10 ES ES95908927T patent/ES2171533T3/en not_active Expired - Lifetime
- 1995-02-10 DK DK95908927T patent/DK0744946T3/en active
- 1995-02-10 RU RU96118271A patent/RU2137473C1/en active
- 1995-02-10 PT PT95908927T patent/PT744946E/en unknown
- 1995-02-10 JP JP52156295A patent/JP3810079B2/en not_active Expired - Lifetime
- 1995-02-10 BR BR9506828A patent/BR9506828A/en not_active IP Right Cessation
- 1995-02-10 PL PL95315973A patent/PL178505B1/en unknown
- 1995-02-10 DE DE69525241T patent/DE69525241T2/en not_active Expired - Lifetime
- 1995-02-10 CZ CZ19962346A patent/CZ290844B6/en not_active IP Right Cessation
- 1995-02-10 AT AT95908927T patent/ATE212547T1/en active
- 1995-02-10 CN CN95191662A patent/CN1112921C/en not_active Expired - Lifetime
- 1995-02-10 MX MX9603314A patent/MX9603314A/en unknown
- 1995-02-10 CA CA002182582A patent/CA2182582C/en not_active Expired - Fee Related
- 1995-02-10 SK SK1058-96A patent/SK283250B6/en not_active IP Right Cessation
- 1995-02-10 NZ NZ279822A patent/NZ279822A/en not_active IP Right Cessation
- 1995-02-15 IL IL11265995A patent/IL112659A/en not_active IP Right Cessation
- 1995-02-16 MY MYPI95000396A patent/MY115339A/en unknown
- 1995-02-16 ZA ZA951294A patent/ZA951294B/en unknown
-
1996
- 1996-08-16 NO NO19963439A patent/NO314712B1/en not_active IP Right Cessation
- 1996-08-16 FI FI963227A patent/FI117888B/en not_active IP Right Cessation
-
2002
- 2002-07-15 CY CY0200045A patent/CY2329B1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL112659A0 (en) | Pharmaceutical compositions containing nebivolol | |
DE69522947D1 (en) | Phenylxanthin-derivate | |
AU4264396A (en) | Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof | |
IL108520A0 (en) | Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them | |
IL110582A (en) | Substituted azadioxacycloalkenes their preparation and fungicidal compositions containing them | |
IL110494A0 (en) | Perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them | |
HU9601218D0 (en) | Distamycin a analogue utilizable as antitumoral and antiviral medicines | |
IL114598A0 (en) | Triazole compounds their preparation and pharmaceutical compositions containing them | |
IL114241A0 (en) | Thiazolidine derivatives their preparation and compositions containing them | |
FI972434A0 (en) | Pharmaceutical composition containing lamotrigine | |
HU9601511D0 (en) | N-substituted azabicycloheptane derivatives used, for example, as neuroleptics | |
HU9602413D0 (en) | Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same | |
SG82540A1 (en) | N-substituted azabicyclo [3.2.0] heptane derivatives as neuroleptics, the preparation and use thereof | |
ZA9429B (en) | Pyrrolidine derivatives their preparation and medicaments containing them | |
IL114719A0 (en) | N-substituted azabicycloheptane derivatives their preparation and use thereof | |
IL107520A0 (en) | Substituted ortho-ethenylphenylacetic acid derivatives and pharmaceutical compositions containing them | |
TW261605B (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HFG4 | Patent granted, date of granting |
Effective date: 20021205 |